Analyst consensus rating
Kiora Pharmaceuticals Analyst Rating: Buy
KPRX is rated Buy by 1 analysts with a $12.00 target. As of 2026-08-20.
Direct answer
Kiora Pharmaceuticals's consensus rating is Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.00.
Forecast evidence checked August 20, 2026.
Get free Kiora Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.60
- Average price target
- $12.00
- High price target
- $12.00
- Low price target
- $12.00
- Low target gap
- +361.5%
- Target upside
- +361.5%
- High target gap
- +361.5%
- Target range width
- 0%
- Consensus rating
- Buy
- Analysts
- 1
- Evidence date
- August 20, 2026
- Valid through
- August 27, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Kiora Pharmaceuticals?
Kiora Pharmaceuticals has a verified Buy consensus. The same dataset has an average price target of $12.00.
How far are Kiora Pharmaceuticals's low and high targets from the recorded price?
The low target implies +361.5%, while the high target implies +361.5%.
How many analysts are included in Kiora Pharmaceuticals's consensus?
The verified consensus includes 1 analysts.
How is Kiora Pharmaceuticals's target upside or downside calculated?
The average target of $12.00 is divided by the recorded price of $2.60, then one is subtracted to produce +361.5%. This does not guarantee a future return.
When was Kiora Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-20. The dataset is valid through 2026-08-27.